The Arizona CoVHORT research study at the University of Arizona has received $3.2 million in funding to investigate the links between long COVID and gastrointestinal symptoms, specifically irritable bowel syndrome (IBS). Led by epidemiologist Kristen Pogreba-Brown, the study aims to determine how COVID-19 impacts the incidence of IBS, offering potential benefits to millions affected by the ongoing pandemic.
Breakthrough recombinase technology ushers in precise, adaptable gene editing
A team of researchers at the Carl Gustav Carus Faculty of Medicine, TUD Dresden University of Technology, led by Prof. Frank Buchholz, has achieved a
February 2, 2024